Switching tumor necrosis factor inhibitors: an opinion-Reference-Cited by-同舟云学术

Switching tumor necrosis factor inhibitors: an opinion

Published:2006-11 Issue:11 Volume:2 Page:576-577
ISSN:1745-8382
Container-title:Nature Clinical Practice Rheumatology
language:en
Short-container-title:Nat Rev Rheumatol

Author:

Keystone Edward C

Publisher

Springer Science and Business Media LLC

Subject

Rheumatology

Link

http://www.nature.com/articles/ncprheum0339.pdf

Reference10 articles.

1. Scallon B et al. (2002) Binding and functional comparisons of two types of tumor necrosis factor antagonists. J Pharmacol Exp Ther 301: 418–426

2. Villeneuve E and Haraoui B (2006) Switching between TNF-α inhibitors in the treatment of Rheumatoid arthritis. Int J Advances Rheumatol 4: 2–8

3. Buch MH and Emery P (2006) Nonresponse to tumor necrosis factor antagonists—is there any point in re-treatment? Nat Clin Pract Rheumatol 2: 288–289

4. Bombarderi S et al. (2005) Fetal adalimumab is effective in treating patients with rheumatoid arthritis who previously failed etanercept and/or infliximab in real-life settings. Arthritis Rheum 52 (Suppl 9): S144

5. Nikas SN et al. (2005) The efficacy and safety to switching from infliximab to adalimumab: A comparative controlled study. Ann Rheum Dis 65: 257–260

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors Influencing Placebo Responses in Rheumatoid Arthritis Clinical Trials: A Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Studies;Clinical Drug Investigation;2020-01-17

2. Clinical response to golimumab in rheumatoid arthritis patients who were receiving etanercept or adalimumab: results of a multicenter active treatment study;Current Medical Research and Opinion;2017-01-25

3. Biological therapies in rheumatic diseases;CLIN TER;2013

4. The efficacy of biologic agents in patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor inhibitors: a systematic review;Rheumatology;2012-09-01

5. Biologic Agents in Rheumatic Diseases;Korean Journal of Medicine;2012